Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-24

Clinical Trial Update: Comparison Study of PTHrP and PTH to Treat Osteoporosis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing abaloparatide (PTHrP) with teriparatide (PTH) for osteoporosis completed, and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forteo (teriparatide)
  • Tymlos (abaloparatide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2016-02-24